Beyond Air Secures $30M for Global Growth | Business and Finance News

Beyond Air just landed $30M in fresh funding to turn things around, regain Nasdaq compliance, and turbocharge its LungFit PH system rollout. Revenue held steady at $1.8M Q1 2027, but behind the scenes, they’ve inked a major U.S. GPO deal and expanded globally into over 40 countries. The real spotlight? Their pending FDA approval for the next-gen LungFit PH — submitted in June 2025, expected by late 2026 — which could catapult revenue from $8M in 2026 to $16–18M in 2027, marking over 100% growth. This is the moment Beyond Air is building for: global scale, regulatory momentum, and explosive expansion. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/b8fdb224a352c481